首页> 外文期刊>Pigment cell & melanoma research >Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma
【24h】

Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma

机译:微小RNA生物发生机制中的畸变和微小RNA在皮肤恶性黑色素瘤发病机理中的新兴作用

获取原文
获取原文并翻译 | 示例
           

摘要

Micro-RNAs (miRNAs) are small noncoding RNAs that play roles in the posttranscriptional regulation of gene expression. Since the seminal discovery that aberrant miRNA expression has a causative role in leukemogenesis, the involvement of miRNAs in cancer initiation, propagation, and metastasis has been widely studied. In this review, we provide a comprehensive summary of the literature on miRNAs in melanoma, specifically focusing on aberrations in cellular miRNA biogenesis and processing. These aberrations include genetic and epigenetic changes at the chromosomal level, alterations in the level of the miRNA-processing enzyme DICER, and the existence of competitive endogenous RNAs that serve as decoys for miRNAs and thus modulate their effective intracellular concentrations. We also discuss miRNA profiling in melanoma, review several miRNAs implicated in invasion, metastasis, proliferation, and apoptosis, and briefly summarize the cross talk between miRNAs and microphthalmia-associated transcription factor, the master transcriptional regulator of the melanocyte lineage. Finally, we summarize recent studies of miRNA expression as prognostic and predictive biomarkers, as well as initial experiments on the use of miRNAs and small interfering RNAs as therapeutic agents in melanoma.
机译:微小RNA(miRNA)是小的非编码RNA,在基因表达的转录后调控中发挥作用。自开创性的发现,异常的miRNA表达在白血病发生中具有致病作用以来,已经广泛研究了miRNA在癌症的发生,扩散和转移中的参与。在这篇综述中,我们提供了有关黑色素瘤中miRNA的文献的全面摘要,特别着重于细胞miRNA生物发生和加工中的畸变。这些畸变包括染色体水平的遗传和表观遗传变化,miRNA加工酶DICER水平的变化,以及竞争性内源RNA的存在,这些竞争性内源RNA可以作为miRNA的诱饵,从而调节其有效的细胞内浓度。我们还讨论了黑色素瘤中的miRNA分析,回顾了几种与侵袭,转移,增殖和凋亡相关的miRNA,并简要总结了miRNA与小眼症相关转录因子(黑素细胞谱系的主要转录调节因子)之间的相互作用。最后,我们总结了miRNA表达作为预后和预测性生物标志物的最新研究,以及使用miRNA和小干扰RNA作为黑色素瘤治疗剂的初步实验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号